These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 22481199)
21. Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study. Roth N; Biedermann L; Fournier N; Butter M; Vavricka SR; Navarini AA; Rogler G; Scharl M; PLoS One; 2019; 14(1):e0210436. PubMed ID: 30682031 [TBL] [Abstract][Full Text] [Related]
22. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study. Moravvej H; Razavi GM; Farshchian M; Malekzadeh R Indian J Dermatol Venereol Leprol; 2008; 74(6):607-10. PubMed ID: 19171983 [TBL] [Abstract][Full Text] [Related]
23. Mucocutaneous manifestations in inflammatory bowel disease. Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896 [TBL] [Abstract][Full Text] [Related]
24. Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population. Jo UH; Lee JY; Lee H; Kim DY; Kang S; Koh SJ; Park H J Dermatol; 2021 Apr; 48(4):431-438. PubMed ID: 33608949 [TBL] [Abstract][Full Text] [Related]
25. Dermatologic manifestations in pediatric patients with inflammatory bowel disease. Afarideh M; Bartoletta K; Tollefson MM Pediatr Dermatol; 2024; 41(2):234-242. PubMed ID: 38326222 [TBL] [Abstract][Full Text] [Related]
26. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease. Dubinsky MC; Cross RK; Sandborn WJ; Long M; Song X; Shi N; Ding Y; Eichner S; Pappalardo B; Ganguli A; Wang A Inflamm Bowel Dis; 2018 Aug; 24(9):1876-1882. PubMed ID: 29668916 [TBL] [Abstract][Full Text] [Related]
27. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease. King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933 [TBL] [Abstract][Full Text] [Related]
28. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease. Ciccacci C; Biancone L; Di Fusco D; Ranieri M; Condino G; Giardina E; Onali S; Lepre T; Pallone F; Novelli G; Borgiani P J Crohns Colitis; 2013 Feb; 7(1):44-52. PubMed ID: 22445837 [TBL] [Abstract][Full Text] [Related]
30. [Extra intestinal manifestations of Crohn's disease (author's transl)]. Preel JL; Weissman A; Hardouin JP; Debray C Sem Hop; 1979 Mar 18-25; 55(1112):552-9. PubMed ID: 224470 [TBL] [Abstract][Full Text] [Related]
31. Inflammatory bowel disease in Iran: a review of 457 cases. Aghazadeh R; Zali MR; Bahari A; Amin K; Ghahghaie F; Firouzi F J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187 [TBL] [Abstract][Full Text] [Related]
32. [Cutaneous symptoms of ulcero-haemorragic rectocolitis and of Crohn's disease (author's transl)]. Thivolet J; Ortonne JP; Jeune R Ann Dermatol Venereol; 1978; 105(8-9):723-7. PubMed ID: 367248 [TBL] [Abstract][Full Text] [Related]
33. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Apgar JT Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561 [TBL] [Abstract][Full Text] [Related]
34. [Erythema nodosum and Crohn's disease]. Areias E; García E Silva L Med Cutan Ibero Lat Am; 1984; 12(6):489-95. PubMed ID: 6152299 [TBL] [Abstract][Full Text] [Related]
35. Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD. Tremaine WJ Inflamm Bowel Dis; 1998 Feb; 4(1):68-9; discussion 73. PubMed ID: 9552230 [No Abstract] [Full Text] [Related]
36. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. Dotson JL; Hyams JS; Markowitz J; LeLeiko NS; Mack DR; Evans JS; Pfefferkorn MD; Griffiths AM; Otley AR; Bousvaros A; Kugathasan S; Rosh JR; Keljo D; Carvalho RS; Tomer G; Mamula P; Kay MH; Kerzner B; Oliva-Hemker M; Langton CR; Crandall W J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):140-5. PubMed ID: 20453677 [TBL] [Abstract][Full Text] [Related]
37. [Inflammatory intestinal diseases and their extra-intestinal manifestations observed at Liban]. Ghayad E; Haddad F; el Aam C; Tohmé A; Nasr W J Med Liban; 1997 Dec; 45(4):191-6. PubMed ID: 9747008 [TBL] [Abstract][Full Text] [Related]
38. [Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis]. Richter L; Rappersberger K Hautarzt; 2016 Dec; 67(12):940-947. PubMed ID: 27830291 [TBL] [Abstract][Full Text] [Related]
39. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Farhi D; Cosnes J; Zizi N; Chosidow O; Seksik P; Beaugerie L; Aractingi S; Khosrotehrani K Medicine (Baltimore); 2008 Sep; 87(5):281-293. PubMed ID: 18794711 [TBL] [Abstract][Full Text] [Related]
40. Mucocutaneous manifestations of inflammatory bowel disease in central China -a single-centre study. Kou CX; Zhang YY; Li GW; Li J; Kong QT; Chen J; Liu F; Zhang M; Wang FY; Jiang Y; Hao LY; Ren JA; Sang H J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e211-e212. PubMed ID: 29194792 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]